Medical Research News

Nursing

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Lewiecki EM - Denosumab is a promising therapeutic agent for the management of postmenopausal osteoporosis and rheumatoid arthritis.

Related Articles

Effects of Denosumab on Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
The Journal of Urology, 11/16/09    Relevance Score: 87%

A New Drug in a New Class for Postmenopausal Osteoporosis
The Female Patient, 11/11/09    Relevance Score: 83%

Bone health and prostate cancer
Prostate Cancer & Prostatic Diseases, 11/13/09    Relevance Score: 77%

Today in Clinical Pharmacology...keeping you current

Management of hypertension with fixed dose combinations of candesartan cilexetil and hydrochlorothiazide: patient perspectives and clinical utility
Vascular Health and Risk Management, 12/01/09

Continuation of Low-Dose Aspirin in Peptic Ulcer Bleeding. A Randomized Trial
Annals of Internal Medicine, 12/01/09

An evidence-based review of natalizumab therapy in the management of Crohn’s disease
Therapeutics and Clinical Risk Management, 12/01/09

Today in Women`s Health...keeping you current

Women Have a Lower Prevalence of Structural Heart Disease as a Precursor to Sudden Cardiac Arrest
JACC - Journal of the American College of Cardiology, 12/01/09

Effect of methylphenidate on fatigue in women with recurrent gynecologic cancer
Psycho-Oncology, 12/01/09

Older women, breast cancer, and social support
Supportive Care in Cancer, 12/01/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address